https://www.zacks.com/stock/news/2212081/compared-to-estimates-m-t-bank-corporation-mtb-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2212081
Jan 18, 2024 - While the top- and bottom-line numbers for M&T Bank Corporation (MTB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:8653296328247734161
0
https://www.zacks.com/stock/news/2213002/unveiling-at-t-t-q4-outlook-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2213002
Jan 19, 2024 - Get a deeper insight into the potential performance of AT&T (T) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
zc:-1238392832880229176
0
https://www.zacks.com/stock/news/2214498/unlocking-q4-potential-of-t-mobile-tmus-exploring-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2214498
Jan 23, 2024 - Beyond analysts' top -and-bottom-line estimates for T-Mobile (TMUS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
zc:-1412424082911933187
0
https://www.zacks.com/stock/news/2216184/compared-to-estimates-t-mobile-tmus-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2216184
Jan 25, 2024 - Although the revenue and EPS for T-Mobile (TMUS) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-4959990660878944221
0
https://www.zacks.com/stock/news/2215952/s-t-bancorp-stba-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2215952
Jan 25, 2024 - While the top- and bottom-line numbers for S&T Bancorp (STBA) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:6778527209577036237
0
https://www.zacks.com/commentary/2219543/top-research-reports-for-abbott-t-mobile-booking?cid=CS-ZC-FT-research_daily-2219543
Feb 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).
zc:-2929895383254301058
0
https://www.zacks.com/stock/news/2219670/t-rowe-price-trow-to-post-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2219670
Feb 01, 2024 - T. Rowe Price (TROW) is expected to have witnessed an improvement in AUM in the fourth quarter of 2023 due to favourable equity market performance partially offset by net outflows.
zc:-1444630457733048380
0
https://www.zacks.com/stock/news/2219608/t-rowe-price-trow-expected-to-beat-earnings-estimates-should-you-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2219608
Feb 01, 2024 - T. Rowe (TROW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:7236407796846359591
0
https://www.zacks.com/stock/news/2221922/bristol-myers-bmy-tsvt-car-t-cell-therapy-to-face-fda-s-odac?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221922
Feb 06, 2024 - Bristol Myers (BMY) and its partner TSVT announce that the FDA's ODAC will meet in March to review data supporting the label expansion for CAR T-cell therapy.
zc:8567294693272462537
0
https://www.zacks.com/stock/news/2223559/t-rowe-price-trow-q4-earnings-beat-estimates-aum-rises-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2223559
Feb 08, 2024 - T. Rowe Price's (TROW) Q4 earnings beat estimates on increased net revenues, an improvement in AUM and a decline in expenses. A rise in cash and cash equivalents will help it continue investing.
zc:-6853405466055614972
0